Parathyroid hormone is predictive of low bone mass in Canadian Aboriginal and White women

Bone

Volumn 42, Issue 3, 2008, Pages 498-504

  Weiler, Hope A ^a   Leslie, William D ^b   Bernstein, Charles N ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aboriginal; Bone mass; Parathyroid hormone; Vitamin D; Women

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCIUM PHOSPHATE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; VITAMIN D;

ABORIGINE; ADULT; AGE; AGED; ARTICLE; BLOOD CHEMISTRY; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CANADA; CAUCASIAN; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; FEMALE; FRACTURE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; STATISTICAL ANALYSIS;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CANADA; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; PARATHYROID HORMONE; POPULATION GROUPS; PREDICTIVE VALUE OF TESTS; VITAMIN D;

EID: 39149140691     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.11.013     Document Type: Article

References (31)

1. Leslie W.D., Metge C.J., Weiler H.A., Doupe M., Wood Steiman P., and O'Neil J.D. Bone density and bone area in Canadian Aboriginal women: the First Nations bone health study. Osteoporos Int 17 12 (2006) 1755-1762
2. Weiler H.A.., Leslie W.D., Krahn J., Wood Steiman P., and Metge C.J. Canadian Aboriginal women have a higher prevalence of vitamin D deficiency than non-Aboriginal women status despite similar dietary vitamin D intakes. J Nutr 137 2 (2007) 461-462
3. Perry III H.M., Bernard M., Horowitz M., Miller D.K., Fleming S., Baker M.Z., et al. The effect of aging on bone mineral metabolism and bone mass in native American women. J Am Geriatr Soc 46 (1998) 1418-1422
4. Leslie W.D., Derksen S., Metge C., Lix L.M., Salamon E.A., Wood Steiman P., et al. Fracture risk among First Nations people: a retrospective matched cohort study. CMAJ 171 (2004) 869-873
5. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride (1997), National Academy Press, Washington, DC
6. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7 (1997) 439-443
7. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
8. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., and Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77 (2003) 204-210
9. Vieth R., Chan P.C., and MacFarlane G.D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73 (2001) 288-294
10. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69 (1999) 842-856
11. Rucker D., Allan J.A., Fick G.H., and Hanley D.A. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 166 (2002) 1517-1524
12. Guillemant S., Guillemant J., Feteanu D., and Sebag-Lanoe R. Effect of vitamin D3 administration on serum 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and osteocalcin in vitamin D-deficient elderly people. J Steroid Biochem 33 (1989) 1155-1159
13. Aubin J.E., and Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11 (2000) 905-913
14. Szulc P., Hofbauer L.C., Heufelder A.E., Roth S., and Delmas P.D. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86 (2001) 3162-3165
15. Huang J.C., Sakata T., Pfleger L.L., Bencsik M., Halloran B.P., Bikle D.D., et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19 (2004) 235-244
16. Locklin R.M., Khosla S., Turner R.T., and Riggs B.L. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89 (2003) 180-190
17. Bhattoa H.P., Bettembuk P., Ganacharya S., and Balogh A. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int 15 (2004) 447-451
18. Hampson G., Martin F.C., Moffat K., Vaja S., Sankaralingam S., Cheung J., et al. Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial. Osteoporos Int 14 (2003) 750-756
19. Tenenhouse A., Joseph L., Kreiger N., Poliquin S., Murray T.M., Blondeau L., et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11 (2000) 897-904
20. Brown J.P., and Josse R.G. clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 (2002) S1-S34
21. Leib E.S., Lewiecki E.M., Binkley N., and Hamdy R.C. Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7 (2004) 1-6
22. Bernstein C.N., Sargent M., and Leslie W.D. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflamm Bowel Dis 11 (2005) 325-330
23. Szulc P., Munoz F., Marchand F., Chapuy M.C., and Delmas P.D. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Calcif Tissue Int 73 (2003) 520-530
24. Martinez Diaz-Guerra G., Hawkins F., Rapado A., Ruiz Diaz M.A., and Diaz-Curiel M. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight. Osteoporos Int 12 (2001) 178-184
25. Ooms M.E., Lips P., Roos J.C., van der Vijgh W.J., Popp-Snijders C., Bezemer P.D., et al. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10 (1995) 1177-1184
26. Theiler R., Stahelin H.B., Tyndall A., Binder K., Somorjai G., and Bischoff H.A. Calcidiol, calcitriol and parathyroid hormone serum concentrations in institutionalized and ambulatory elderly in Switzerland. Int J Vitam Nutr Res 69 (1999) 96-105
27. Pasco J.A., Henry M.J., Kotowicz M.A., Sanders K.M., Seeman E., Pasco J.R., et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong osteoporosis study. J Bone Miner Res 19 (2004) 752-758
28. Roy D.K., Berry J.L., Pye S.R., Adams J.E., Swarbrick C.M., King Y., et al. Vitamin D status and bone mass in UK South Asian women. Bone 40 1 (2007) 200-204
29. Duan Y., De Luca V., and Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84 (1999) 718-722
30. Sherman S.S., Tobin J.D., Hollis B.W., Gundberg C.M., Roy T.A., and Plato C.C. Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res 7 (1992) 1123-1130
31. Garnero P., Sornay-Rendu E., Claustrat B., and Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15 (2000) 1526-1536